Hoffmann Rainer, Nitendo Giadino, Deserno Verena, Adamu Umar, Almalla Mohammed, Blindt Rüdiger, Vogt Felix
Medical Clinic I, University RWTH Aachen, 52057 Aachen, Germany.
Coron Artery Dis. 2010 Mar;21(2):61-4. doi: 10.1097/MCA.0b013e328332ee4b.
Acute occlusion of saphenous vein grafts resulting in acute coronary syndromes may be treated with interventional revascularization. Few data are available on intermediate and long-term results after revascularization of acute saphenous vein graft occlusion.
Fifty patients (67+/-10 years, 47 male) with troponin-positive acute coronary syndrome because of acute total or subtotal occlusion [thrombolysis in myocardial infarction (TIMI) flow 0=39, TIMI 1=8, TIMI 2=3] of one saphenous vein graft (12.0+/-5.3 years after surgery, 3.6+/-0.9 grafts) were treated with percutaneous coronary intervention (39 patients using bare-metal stents, 11 patients using drug-eluting stents). Clinical follow-up was obtained in all patients. Angiographic 6-month follow-up was performed in 35 patients (70%).
Acute revascularization of the infarct-related saphenous vein graft (lesion length 17.6+/-10.3 mm, reference diameter 3.1+/-0.8 mm) was possible in 94% of patients. After a mean follow-up of 32.5+/-17.4 months, 13 patients (26%) died, 13 patients (26%) had recurrent myocardial infarction, and 20 patients (40%) had recurrent coronary revascularization (percutaneous coronary intervention or coronary artery bypass grafting). Angiographic follow-up showed reocclusion of the vein graft in three cases (9%). Twenty-one percent of lesions were found to be restenotic.
Acute revascularization of an infarct-related saphenous vein graft is possible in the majority of cases. Angiographic follow-up data show a high patency rate at 6-month follow-up. Still, the clinical prognosis of patients with revascularized infarct-related saphenous vein graft is quite poor.
导致急性冠状动脉综合征的大隐静脉移植物急性闭塞可通过介入性血管重建术进行治疗。关于急性大隐静脉移植物闭塞血管重建术后的中长期结果,可用数据较少。
50例患者(年龄67±10岁,男性47例)因一根大隐静脉移植物(术后12.0±5.3年,3.6±0.9根移植物)发生急性完全或次全闭塞[心肌梗死溶栓治疗(TIMI)血流0级=39例,TIMI 1级=8例,TIMI 2级=3例]导致肌钙蛋白阳性急性冠状动脉综合征,接受了经皮冠状动脉介入治疗(39例患者使用裸金属支架,11例患者使用药物洗脱支架)。所有患者均获得临床随访。35例患者(70%)进行了6个月的血管造影随访。
94%的患者梗死相关大隐静脉移植物(病变长度17.6±10.3mm,参考直径3.1±0.8mm)实现了急性血管重建。平均随访32.5±17.4个月后,13例患者(26%)死亡,13例患者(26%)发生复发性心肌梗死,20例患者(40%)进行了复发性冠状动脉血管重建(经皮冠状动脉介入治疗或冠状动脉旁路移植术)。血管造影随访显示3例(9%)静脉移植物再次闭塞。21%的病变被发现有再狭窄。
大多数情况下梗死相关大隐静脉移植物可实现急性血管重建。血管造影随访数据显示6个月随访时通畅率较高。然而,梗死相关大隐静脉移植物血管重建患者的临床预后相当差。